Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 28 Leukemia, Lymphocytic, Chronic, B-Cell 14 Myelodysplastic Syndromes 6 Waldenstrom Macroglobulinemia 5 Lymphoma, B-Cell, Marginal Zone 5 Burkitt Lymphoma 5 Lymphoma, Mantle-Cell 4 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma 3 Recurrence 2 Neoplasms 2 Myeloproliferative Disorders 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Biphenotypic, Acute 2 Leukemia 2 Hematologic Neoplasms 2 Blast Crisis 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myeloid 1 GATA2 Deficiency 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Dexamethasone 44 Lenalidomide 29 Bortezomib 23 daratumumab 22 pomalidomide 19 Cyclophosphamide 15 carfilzomib 14 Specimen Handling 14 Biopsy 14 Calcium Dobesilate 12 Magnetic Resonance Spectroscopy 10 talquetamab 9 isatuximab 9 Melphalan 8 iberdomide 7 fludarabine 7 belantamab mafodotin 6 dexamethasone acetate 5 dexamethasone 21-phosphate 5 auricularum 5 X-Rays 5 tocilizumab 4 selinexor 4 fludarabine phosphate 4 elotuzumab 4 Nuclear Medicine Department, Hospital 4 trametinib 3 dabrafenib 3 Whole-Body Irradiation 3 Thalidomide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × venetoclax × 30 days × Clear all

NCT05853965 2026-05-18

BELI(E)VE

Universitätsklinikum Hamburg-Eppendorf

Phase 1/2 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡